July 3, 2014, NIAID Funding Newsletter
Read this full issue online at http://www.niaid.nih.gov/
More Perspectives From NIAID's Experiences With Open Data Sharing You're likely aware that several major journals, scientific organizations, foundations, and government agencies, including NIH, are working on new policies designed to improve data sharing. Read the full article.
Opportunities and Resources
Advancing the Efficacy of Topical HIV Microbicides Investigators who missed out on last year’s funding opportunity announcement (FOA) Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (IPCP-MBP) will be excited to learn that NIH has reissued the FOA. Read the full article.
For Your Consideration: Funding Opportunities on HIV Persistence Two funding opportunity announcements (FOAs)—a companion R01 and R21—may be of interest if your research can help increase understanding of persistent HIV-1 infection in patients receiving highly active antiretroviral therapy (HAART).Read the full article.
Opportunities for Multidisciplinary Studies of HIV and Viral Hepatitis Coinfection For pepole infected with HIV, viral hepatitis progresses more rapidly. Read the full article.
In The News
News and Notes From NIAID's Advisory Council If you missed the June 2, 2014, meeting of our advisory Council, read on for a few notes of interest to extramural researchers. Read the full article.
Your Insight Into NIAID's Funding Priorities: Council-Approved Concepts While we're on the topic of Council, if you're not tuned into our concepts, you might be missing out on big insights into NIAID's strategic thinking. Read the full article.
Tips for Writing a Strong Multiple PI Leadership Plan As you prepare to write your multiple PI application, give time and attention to the required Leadership Plan. Read the full article.
- Which publications should I list in my progress report?
- Do I still qualify as an early-stage investigator if my collaborators are established principal investigators?
New Funding Opportunities
- RFA-AI-14-026, Development of Novel Therapeutics for Select Pathogens
- RFA-AI-14-020, Innovative Assays to Quantify the Latent HIV Reservoir
See other announcements at NIAID Funding Opportunities List.
Send suggestions or comments to email@example.com .